Development of Anti-neutrophil Cytoplasmic Antibodies (ANCA) and Vasculitis in BALB/c Mice: A Prototype of Human ANCA Associated Disease

被引:0
|
作者
Pradhan, Vandana D. [1 ]
Ghosh, K. [1 ]
机构
[1] King Edward Mem Hosp, Indian Council Med Res, Natl Inst Immunohaematol, Dept Autoimmune Disorders, Mumbai 4000012, Maharashtra, India
关键词
Anti-neutrophil cytoplasmic antibodies (ANCA); BALB/c mice; vasculitis; myeloperoxidase (MPO); proteinase3 (PR3); GLOMERULONEPHRITIS; AUTOANTIBODIES; MYELOPEROXIDASE; MODEL;
D O I
10.1080/09712119.2009.9707080
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
To investigate whether immunization in BALB/c mice with ANCA will induce ANCA associated vasculitis that will serve as an animal model for the diseased mice were immunized with myeloperoxidase (MPO), proteinase3 (PR3) and 'a granule' extract of polymorphonuclear leukocytes (PMN) using purified human whole antibody to MPO and PR3 and also the F(ab')(2) fractions of MPO-ANCA and PR3-ANCA. Control mice were immunized with normal human IgG. Mice immunized with purified MPO and PR3 as well as with human IgG-ANCA and its F(ab')(2) fractions, developed ANCA and AAV, while control mice did not develop these autoantibodies or the disease. This ANCA could be induced in BALB/c mice by antigen and antibody immunizations and these mice showed the possible development of ANCA related vasculitis indicating a likely pathogenic role of ANCA.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 50 条
  • [1] Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis
    Osman, Mohammed S.
    Tervaert, Jan Willem Cohen
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (12)
  • [2] Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis
    Savage, C. O. S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 23 - 26
  • [3] Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a “Personalized Medicine Approach” in ANCA-Associated Vasculitis
    Mohammed S. Osman
    Jan Willem Cohen Tervaert
    Current Rheumatology Reports, 2019, 21
  • [4] CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis
    Plinio R Hurtado
    Lisa Jeffs
    Jodie Nitschke
    Mittal Patel
    Ghafar Sarvestani
    John Cassidy
    Pravin Hissaria
    David Gillis
    Chen Au Peh
    BMC Immunology, 9
  • [5] Avacopan for the Treatment of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
    Alihosseini, Christopher
    Kopelman, Hannah
    Zaino, Mallory
    Feldman, Steven R.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (12) : 1449 - 1454
  • [6] Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go?
    Kallenberg, C. G. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 1 - 3
  • [7] The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis
    Guchelaar, Niels A. D.
    Waling, Manon M.
    Adhin, Anviti A.
    van Daele, Paul L. A.
    Schreurs, Marco W. J.
    Rombach, Saskia M.
    AUTOIMMUNITY REVIEWS, 2021, 20 (01)
  • [8] C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
    Yuan, Jun
    Gou, Shen-Ju
    Huang, Jing
    Hao, Jian
    Chen, Min
    Zhao, Ming-Hui
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (03)
  • [9] Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis
    Niles, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 27 - 30
  • [10] Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment
    Silva, Francisco
    Cisternas, Marcela
    REVISTA MEDICA DE CHILE, 2013, 141 (06) : 765 - 773